![5AL 5AL](https://data.pdbj.org/pdbjplus/data/cc/svg/5AL.svg) | 5AL | 表記: | 5'-O-[(R)-{[(2S)-2-aminopropanoyl]oxy}(hydroxy)phosphoryl]adenosine | 組成式: | C13 H19 N6 O8 P | SMILES: | O=P(OC(=O)C(N)C)(O)OCC3OC(n2cnc1c(ncnc12)N)C(O)C3O | InChi: | InChI=1S/C13H19N6O8P/c1-5(14)13(22)27-28(23,24)25-2-6-8(20)9(21)12(26-6)19-4-18-7-10(15)16-3-17-11(7)19/h3-6,8-9,12,20-21H,2,14H2,1H3,(H,23,24)(H2,15,16,17)/t5-,6+,8+,9+,12+/m0/s1 | 別名: | Alanyl Adenylate | 定義日: | 2009-06-25 | 最終更新日: | 2021-03-01 | 識別子(ID): | 5'-O-[(R)-{[(2S)-2-aminopropanoyl]oxy}(hydroxy)phosphoryl]adenosine |
|
![5BQ 5BQ](https://data.pdbj.org/pdbjplus/data/cc/svg/5BQ.svg) | 5BQ | 表記: | 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione | 組成式: | C14 H13 Cl O5 S | SMILES: | O=C1C(C(CCC1)=O)C(=O)c2ccc(cc2Cl)S(=O)(C)=O | InChi: | InChI=1S/C14H13ClO5S/c1-21(19,20)8-5-6-9(10(15)7-8)14(18)13-11(16)3-2-4-12(13)17/h5-7,13H,2-4H2,1H3 | 別名: | Sulcotrione | 定義日: | 2015-09-03 | 最終更新日: | 2021-03-01 | 公開日: | 2016-09-07 | 識別子(ID): | 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione |
|
![LXL LXL](https://data.pdbj.org/pdbjplus/data/cc/svg/LXL.svg) | LXL | 表記: | 1-ethyl-3-[2-methoxy-4-(5-methyl-4-{[(1S)-1-(pyridin-3-yl)butyl]amino}pyrimidin-2-yl)phenyl]urea | 組成式: | C24 H30 N6 O2 | SMILES: | CCNC(=O)Nc1ccc(cc1OC)c2ncc(C)c(n2)NC(CCC)c3cnccc3 | InChi: | InChI=1S/C24H30N6O2/c1-5-8-19(18-9-7-12-25-15-18)28-22-16(3)14-27-23(30-22)17-10-11-20(21(13-17)32-4)29-24(31)26-6-2/h7,9-15,19H,5-6,8H2,1-4H3,(H2,26,29,31)(H,27,28,30)/t19-/m0/s1 | 別名: | Lexibulin | 定義日: | 2015-08-28 | 最終更新日: | 2021-03-01 | 公開日: | 2015-11-04 | 識別子(ID): | 1-ethyl-3-[2-methoxy-4-(5-methyl-4-{[(1S)-1-(pyridin-3-yl)butyl]amino}pyrimidin-2-yl)phenyl]urea |
|
![5DK 5DK](https://data.pdbj.org/pdbjplus/data/cc/svg/5DK.svg) | 5DK | 表記: | (E)-N~2~-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)-D-arginine | 組成式: | C14 H22 N5 O7 P | SMILES: | c1(C)ncc(c(c1O)/C=N/C(CCCN/C(N)=N)C(O)=O)COP(O)(O)=O | InChi: | InChI=1S/C14H22N5O7P/c1-8-12(20)10(9(5-18-8)7-26-27(23,24)25)6-19-11(13(21)22)3-2-4-17-14(15)16/h5-6,11,20H,2-4,7H2,1H3,(H,21,22)(H4,15,16,17)(H2,23,24,25)/b19-6+/t11-/m1/s1 | 別名: | PLP-DArg | 定義日: | 2015-09-09 | 最終更新日: | 2021-03-01 | 公開日: | 2015-11-25 | 識別子(ID): | (E)-N~2~-({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methylidene)-D-arginine |
|
![LY3 LY3](https://data.pdbj.org/pdbjplus/data/cc/svg/LY3.svg) | LY3 | 表記: | 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-4-(2H-TETRAZOL-5-YL)-BUTYRIC ACID | 組成式: | C20 H21 N9 O4 | SMILES: | O=C(O)C(NC(=O)c1ccc(cc1)CCc2cnc3N=C(NC(=O)c23)N)CCc4nnnn4 | InChi: | InChI=1S/C20H21N9O4/c21-20-24-16-15(18(31)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(30)23-13(19(32)33)7-8-14-26-28-29-27-14/h1-2,4-5,9,13H,3,6-8H2,(H,23,30)(H,32,33)(H,26,27,28,29)(H4,21,22,24,25,31)/t13-/m0/s1 | 別名: | LY341770 | 定義日: | 2001-08-24 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S)-2-[({4-[2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl}carbonyl)amino]-4-(2H-tetrazol-5-yl)butanoic acid |
|
![LYA LYA](https://data.pdbj.org/pdbjplus/data/cc/svg/LYA.svg) | LYA | 表記: | 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID | 組成式: | C20 H21 N5 O6 | SMILES: | O=C(O)C(NC(=O)c1ccc(cc1)CCc2cnc3NC(=NC(=O)c23)N)CCC(=O)O | InChi: | InChI=1S/C20H21N5O6/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29)/t13-/m0/s1 | 別名: | LY231514 | 定義日: | 2001-08-24 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-({4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl}carbonyl)-L-glutamic acid |
|
![M0E M0E](https://data.pdbj.org/pdbjplus/data/cc/svg/M0E.svg) | M0E | 表記: | MOENOMYCIN | 組成式: | C69 H106 N5 O34 P | SMILES: | O=C(NC1=C(O)C=CC1=O)C6OC(OC2C(O)C(NC(=O)C)C(OC2C)OC4C(OC(OC3C(OC(=O)N)C(O)(C)C(OC3OP(=O)(O)OCC(OCC=C(/C)CC/C=C/C(C)(C)CCC(=C)/CC=C(/C)CCC=C(/C)C)C(=O)O)C(=O)N)C(NC(=O)C)C4O)COC5OC(C(O)C(O)C5O)CO)C(O)C(O)C6O | InChi: | InChI=1S/C69H106N5O34P/c1-30(2)15-14-17-31(3)18-19-33(5)22-25-68(9,10)24-13-12-16-32(4)23-26-96-41(61(90)91)29-98-109(94,95)108-66-56(57(107-67(71)92)69(11,93)58(106-66)59(70)88)105-63-44(73-36(8)77)47(82)54(40(101-63)28-97-64-51(86)48(83)45(80)39(27-75)100-64)103-62-43(72-35(7)76)46(81)53(34(6)99-62)102-65-52(87)49(84)50(85)55(104-65)60(89)74-42-37(78)20-21-38(42)79/h13,15,18,20-21,23-24,34,39-41,43-58,62-66,75,80-87,93H,5,12,14,16-17,19,22,25-29H2,1-4,6-11H3,(H2,70,88)(H2,71,92)(H,72,76)(H,73,77)(H,90,91)(H,94,95)(H2,74,78,79,89)/t34-,39-,40-,41-,43-,44-,45-,46-,47-,48+,49+,50-,51-,52-,53-,54-,55+,56-,57-,58-,62+,63+,64-,65-,66-,69+/m1/s1 | 別名: | MOENOMYCIN | 定義日: | 2007-02-12 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2R)-3-{[(S)-{[(2R,3R,4R,5S,6S)-3-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-4-hydroxy-6-methyl-5-({(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopenta-1,3-dien-1-yl)carbamoyl]tetrahydro-2H-pyran-2-yl}oxy)tetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl]oxy}-6-carbamoyl-4-(carbamoyloxy)-5-hydroxy-5-methyltetrahydro-2H-pyran-2-yl]oxy}(hydroxy)phosphoryl]oxy}-2-[(3,8,8,14,18-pentamethyl-11-methylidenenonadeca-2,6,13,17-tetraen-1-yl)oxy]propanoic acid (non-preferred name) |
|
![M18 M18](https://data.pdbj.org/pdbjplus/data/cc/svg/M18.svg) | M18 | 表記: | {(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate | 組成式: | C20 H27 Cl N2 O5 | SMILES: | O=C(N1CCCC1COC(=O)Cc2cccc(Cl)c2)CNC(=O)OC(C)(C)C | InChi: | InChI=1S/C20H27ClN2O5/c1-20(2,3)28-19(26)22-12-17(24)23-9-5-8-16(23)13-27-18(25)11-14-6-4-7-15(21)10-14/h4,6-7,10,16H,5,8-9,11-13H2,1-3H3,(H,22,26)/t16-/m0/s1 | 別名: | (3-Chloro-Phenyl)-acetic acid (S)-1-(2-tert-butoxycarbonylamino-acetyl)-pyrrolidin-2-ylmethyl ester | 定義日: | 2008-09-11 | 最終更新日: | 2021-03-01 | 識別子(ID): | {(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate |
|
![M1N M1N](https://data.pdbj.org/pdbjplus/data/cc/svg/M1N.svg) | M1N | 表記: | (1R)-3-METHYL-1-{[N-(MORPHOLIN-4-YLCARBONYL)-3-(1-NAPHTHYL)-D-ALANYL]AMINO}BUTYLBORONIC ACID | 組成式: | C23 H32 B N3 O5 | SMILES: | O=C(NC(C(=O)NC(B(O)O)CC(C)C)Cc2c1ccccc1ccc2)N3CCOCC3 | InChi: | InChI=1S/C23H32BN3O5/c1-16(2)14-21(24(30)31)26-22(28)20(25-23(29)27-10-12-32-13-11-27)15-18-8-5-7-17-6-3-4-9-19(17)18/h3-9,16,20-21,30-31H,10-15H2,1-2H3,(H,25,29)(H,26,28)/t20-,21+/m1/s1 | 別名: | N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID | 定義日: | 2006-01-10 | 最終更新日: | 2021-03-01 | 識別子(ID): | [(1R)-3-methyl-1-({(2R)-2-[(morpholin-4-ylcarbonyl)amino]-3-naphthalen-1-ylpropanoyl}amino)butyl]boronic acid (non-preferred name) |
|
![M29 M29](https://data.pdbj.org/pdbjplus/data/cc/svg/M29.svg) | M29 | 表記: | ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE | 組成式: | C11 H15 N O4 S | SMILES: | O=S(=O)(c1ccc(cc1)CCC(=O)OCC)N | InChi: | InChI=1S/C11H15NO4S/c1-2-16-11(13)8-5-9-3-6-10(7-4-9)17(12,14)15/h3-4,6-7H,2,5,8H2,1H3,(H2,12,14,15) | 別名: | 4-PROPYL BENZENESULFONAMIDE ETHYL ESTER | 定義日: | 2006-10-30 | 最終更新日: | 2021-03-01 | 識別子(ID): | ethyl 3-(4-sulfamoylphenyl)propanoate |
|
![M3R M3R](https://data.pdbj.org/pdbjplus/data/cc/svg/M3R.svg) | M3R | 表記: | Methyl phosphonated L-Arginine | 組成式: | C7 H17 N4 O4 P | SMILES: | O=P(O)(NC(C(=O)O)CCCNC(=[N@H])N)C | InChi: | InChI=1S/C7H17N4O4P/c1-16(14,15)11-5(6(12)13)3-2-4-10-7(8)9/h5H,2-4H2,1H3,(H,12,13)(H4,8,9,10)(H2,11,14,15)/t5-/m0/s1 | 別名: | (2S)-5-carbamimidamido-2-[(hydroxy-methyl-phosphoryl)amino]pentanoic acid | 定義日: | 2009-03-20 | 最終更新日: | 2021-03-01 | 識別子(ID): | N~2~-[(R)-hydroxy(methyl)phosphoryl]-L-arginine |
|
![M4M M4M](https://data.pdbj.org/pdbjplus/data/cc/svg/M4M.svg) | M4M | 表記: | 1-amino-9,10-dioxo-4-[(4-sulfamoylphenyl)amino]-9,10-dihydroanthracene-2-sulfonic acid | 組成式: | C20 H15 N3 O7 S2 | SMILES: | O=S(=O)(N)c1ccc(cc1)Nc4c3C(=O)c2ccccc2C(=O)c3c(c(c4)S(=O)(=O)O)N | InChi: | InChI=1S/C20H15N3O7S2/c21-18-15(32(28,29)30)9-14(23-10-5-7-11(8-6-10)31(22,26)27)16-17(18)20(25)13-4-2-1-3-12(13)19(16)24/h1-9,23H,21H2,(H2,22,26,27)(H,28,29,30) | 別名: | 1-amino-4-(4-aminosulfonyl)phenylamino-anthraquinone-2-sulfonic acid | 定義日: | 2011-10-06 | 最終更新日: | 2021-03-01 | 識別子(ID): | 1-amino-9,10-dioxo-4-[(4-sulfamoylphenyl)amino]-9,10-dihydroanthracene-2-sulfonic acid |
|
![M4O M4O](https://data.pdbj.org/pdbjplus/data/cc/svg/M4O.svg) | M4O | 表記: | (2R)-3-{[(S)-{[(2R,3R,4R,5S,6S)-3-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2R,3R,4S,5R,6S)-6-carbamoyl-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl]oxy}-6-carbamoyl-4-(carbamoyloxy)-5-hydroxy-5-methyltetrahydro-2H-pyran-2-yl]oxy}(hydroxy)phosphoryl]oxy}-2-{[(2Z)-3,7-dimethylocta-2,6-dien-1-yl]oxy}propanoic acid | 組成式: | C49 H80 N5 O32 P | SMILES: | O=C(O)C(OC/C=C(/C)CCC=C(/C)C)COP(=O)(O)OC5OC(C(=O)N)C(O)(C)C(OC(=O)N)C5OC4OC(COC1OC(C(O)C(O)C1O)CO)C(OC3OC(C)C(OC2OC(C(=O)N)C(O)C(O)C2O)C(O)C3NC(=O)C)C(O)C4NC(=O)C | InChi: | InChI=1S/C49H80N5O32P/c1-16(2)9-8-10-17(3)11-12-74-23(42(68)69)15-76-87(72,73)86-47-37(38(85-48(52)70)49(7,71)39(84-47)41(51)67)83-44-25(54-20(6)57)28(60)35(22(79-44)14-75-45-32(64)29(61)26(58)21(13-55)78-45)81-43-24(53-19(5)56)27(59)34(18(4)77-43)80-46-33(65)30(62)31(63)36(82-46)40(50)66/h9,11,18,21-39,43-47,55,58-65,71H,8,10,12-15H2,1-7H3,(H2,50,66)(H2,51,67)(H2,52,70)(H,53,56)(H,54,57)(H,68,69)(H,72,73)/b17-11-/t18-,21-,22-,23-,24-,25-,26-,27-,28-,29+,30+,31-,32-,33-,34-,35-,36+,37-,38-,39-,43+,44+,45-,46-,47-,49+/m1/s1 | 別名: | Neryl Moenomycin A | 定義日: | 2008-02-28 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2R)-3-{[(S)-{[(2R,3R,4R,5S,6S)-3-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2R,3R,4S,5R,6S)-6-carbamoyl-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}methyl)tetrahydro-2H-pyran-2-yl]oxy}-6-carbamoyl-4-(carbamoyloxy)-5-hydroxy-5-methyltetrahydro-2H-pyran-2-yl]oxy}(hydroxy)phosphoryl]oxy}-2-{[(2Z)-3,7-dimethylocta-2,6-dien-1-yl]oxy}propanoic acid (non-preferred name) |
|
![M5A M5A](https://data.pdbj.org/pdbjplus/data/cc/svg/M5A.svg) | M5A | 表記: | (2S)-2-[4-(thiophene-2-carbonyl)phenyl]propanoic acid | 組成式: | C14 H12 O3 S | SMILES: | O=C(c1ccc(cc1)C(C)C(O)=O)c2cccs2 | InChi: | InChI=1S/C14H12O3S/c1-9(14(16)17)10-4-6-11(7-5-10)13(15)12-3-2-8-18-12/h2-9H,1H3,(H,16,17)/t9-/m0/s1 | 別名: | (S)-Suprofen | 定義日: | 2019-03-25 | 最終更新日: | 2021-03-01 | 公開日: | 2020-01-15 | 識別子(ID): | (2S)-2-[4-(thiophene-2-carbonyl)phenyl]propanoic acid |
|
![5L9 5L9](https://data.pdbj.org/pdbjplus/data/cc/svg/5L9.svg) | 5L9 | 表記: | (2~{S})-2-(1-chloranylcyclopropyl)-1-(2-chlorophenyl)-3-(1,2,4-triazol-1-yl)propan-2-ol | 組成式: | C14 H15 Cl2 N3 O | SMILES: | O[C](Cn1cncn1)(Cc2ccccc2Cl)C3(Cl)CC3 | InChi: | InChI=1S/C14H15Cl2N3O/c15-12-4-2-1-3-11(12)7-14(20,13(16)5-6-13)8-19-10-17-9-18-19/h1-4,9-10,20H,5-8H2/t14-/m0/s1 | 別名: | S-desthio-prothioconazole | 定義日: | 2015-10-19 | 最終更新日: | 2021-03-01 | 公開日: | 2016-02-10 | 識別子(ID): | (2~{S})-2-(1-chloranylcyclopropyl)-1-(2-chlorophenyl)-3-(1,2,4-triazol-1-yl)propan-2-ol |
|
![5LY 5LY](https://data.pdbj.org/pdbjplus/data/cc/svg/5LY.svg) | 5LY | 表記: | 1-[[(2~{R},4~{R})-2-[2-chloranyl-4-(4-chloranylphenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]-1,2,4-triazole | 組成式: | C19 H17 Cl2 N3 O3 | SMILES: | C[CH]1CO[C](Cn2cncn2)(O1)c3ccc(Oc4ccc(Cl)cc4)cc3Cl | InChi: | InChI=1S/C19H17Cl2N3O3/c1-13-9-25-19(27-13,10-24-12-22-11-23-24)17-7-6-16(8-18(17)21)26-15-4-2-14(20)3-5-15/h2-8,11-13H,9-10H2,1H3/t13-,19+/m1/s1 | 別名: | Difenoconazole | 定義日: | 2015-10-21 | 最終更新日: | 2021-03-01 | 公開日: | 2016-02-10 | 識別子(ID): | 1-[[(2~{R},4~{R})-2-[2-chloranyl-4-(4-chloranylphenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]-1,2,4-triazole |
|
![5LZ 5LZ](https://data.pdbj.org/pdbjplus/data/cc/svg/5LZ.svg) | 5LZ | 表記: | 1-[[(2~{S},4~{R})-2-[2-chloranyl-4-(4-chloranylphenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]-1,2,4-triazole | 組成式: | C19 H17 Cl2 N3 O3 | SMILES: | C[CH]1CO[C](Cn2cncn2)(O1)c3ccc(Oc4ccc(Cl)cc4)cc3Cl | InChi: | InChI=1S/C19H17Cl2N3O3/c1-13-9-25-19(27-13,10-24-12-22-11-23-24)17-7-6-16(8-18(17)21)26-15-4-2-14(20)3-5-15/h2-8,11-13H,9-10H2,1H3/t13-,19-/m1/s1 | 別名: | Difenoconazole | 定義日: | 2015-10-21 | 最終更新日: | 2021-03-01 | 公開日: | 2016-02-10 | 識別子(ID): | 1-[[(2~{S},4~{R})-2-[2-chloranyl-4-(4-chloranylphenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]-1,2,4-triazole |
|
![DLM DLM](https://data.pdbj.org/pdbjplus/data/cc/svg/DLM.svg) | DLM | 表記: | 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromenium | 組成式: | C15 H11 O7 | SMILES: | Oc1cc(cc(O)c1O)c3[o+]c2cc(O)cc(O)c2cc3O | InChi: | InChI=1S/C15H10O7/c16-7-3-9(17)8-5-12(20)15(22-13(8)4-7)6-1-10(18)14(21)11(19)2-6/h1-5H,(H5-,16,17,18,19,20,21)/p+1 | 別名: | Delphinidin | 定義日: | 2014-10-15 | 最終更新日: | 2021-03-01 | 公開日: | 2015-01-21 | 識別子(ID): | 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromenium |
|
![DLP DLP](https://data.pdbj.org/pdbjplus/data/cc/svg/DLP.svg) | DLP | 表記: | 1,2-DILINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 組成式: | C44 H80 N O8 P | SMILES: | O=C(OCC(OC(=O)CCCCCCCC=C/CC=C/CCCCC)COP([O-])(=O)OCC[N+](C)(C)C)CCCCCCCC=C/CC=C/CCCCC | InChi: | InChI=1S/C44H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h14-17,20-23,42H,6-13,18-19,24-41H2,1-5H3/b16-14-,17-15-,22-20-,23-21-/t42-/m1/s1 | 別名: | DI-LINOLEOYL-3-SN-PHOSPHATIDYLCHOLINE | 定義日: | 2002-05-13 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2R)-2,3-bis[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl 2-(trimethylammonio)ethyl phosphate |
|
![DLU DLU](https://data.pdbj.org/pdbjplus/data/cc/svg/DLU.svg) | DLU | 表記: | (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | 組成式: | C20 H19 F2 N3 O5 | SMILES: | Fc1ccc(c(F)c1)CNC(=O)C4=CN3C(C(=O)N2C(CCOC2C3)C)=C(O)C4=O | InChi: | InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1 | 別名: | Dolutegravir | 定義日: | 2011-05-23 | 最終更新日: | 2021-03-01 | 識別子(ID): | (4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
|
![DM2 DM2](https://data.pdbj.org/pdbjplus/data/cc/svg/DM2.svg) | DM2 | 表記: | DOXORUBICIN | 組成式: | C27 H29 N O11 | SMILES: | O=C2c1c(O)c5c(c(O)c1C(=O)c3cccc(OC)c23)CC(O)(C(=O)CO)CC5OC4OC(C(O)C(N)C4)C | InChi: | InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1 | 別名: | ADRIAMYCIN | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside |
|
![DM6 DM6](https://data.pdbj.org/pdbjplus/data/cc/svg/DM6.svg) | DM6 | 表記: | 4'-EPIDOXORUBICIN | 組成式: | C27 H30 N O11 | SMILES: | O=C2c1c(O)c5c(c(O)c1C(=O)c3cccc(OC)c23)CC(O)(C(=O)CO)CC5OC4OC(C(O)C(C4)[NH3+])C | InChi: | InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/p+1/t10-,13-,15-,17-,22-,27-/m0/s1 | 別名: | 4'-EPIADRIAMYCIN | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-ammonio-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside |
|
![DMC DMC](https://data.pdbj.org/pdbjplus/data/cc/svg/DMC.svg) | DMC | 表記: | 3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID | 組成式: | C14 H19 N O3 | SMILES: | O=C(O)/C(=C/c1ccc(cc1O)N(CC)CC)C | InChi: | InChI=1S/C14H19NO3/c1-4-15(5-2)12-7-6-11(13(16)9-12)8-10(3)14(17)18/h6-9,16H,4-5H2,1-3H3,(H,17,18)/b10-8+ | 別名: | PARA-DIETHYLAMINO-O-HYDROXY-ALPHA-METHYL CINNAMIC ACID | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2E)-3-[4-(diethylamino)-2-hydroxyphenyl]-2-methylprop-2-enoic acid |
|
![DMQ DMQ](https://data.pdbj.org/pdbjplus/data/cc/svg/DMQ.svg) | DMQ | 表記: | [4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-1,3-BIS([(3-AMINO)PHENYL]METHYL)-4,7-BIS(PHENYLMETHYL)-2H-1,3-DIAZEPINONE | 組成式: | C33 H36 N4 O3 | SMILES: | O=C1N(C(C(O)C(O)C(N1Cc2cccc(N)c2)Cc3ccccc3)Cc4ccccc4)Cc5cccc(N)c5 | InChi: | InChI=1S/C33H36N4O3/c34-27-15-7-13-25(17-27)21-36-29(19-23-9-3-1-4-10-23)31(38)32(39)30(20-24-11-5-2-6-12-24)37(33(36)40)22-26-14-8-16-28(35)18-26/h1-18,29-32,38-39H,19-22,34-35H2/t29-,30-,31+,32+/m1/s1 | 別名: | DMP450(INHIBITOR OF DUPONT MERCK) | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | (4R,5S,6S,7R)-1,3-bis(3-aminobenzyl)-4,7-dibenzyl-5,6-dihydroxy-1,3-diazepan-2-one |
|
![DMU DMU](https://data.pdbj.org/pdbjplus/data/cc/svg/DMU.svg) | DMU | 表記: | DECYL-BETA-D-MALTOPYRANOSIDE | 組成式: | C22 H42 O11 | SMILES: | O(CCCCCCCCCC)C2OC(C(OC1OC(CO)C(O)C(O)C1O)C(O)C2O)CO | InChi: | InChI=1S/C22H42O11/c1-2-3-4-5-6-7-8-9-10-30-21-19(29)17(27)20(14(12-24)32-21)33-22-18(28)16(26)15(25)13(11-23)31-22/h13-29H,2-12H2,1H3/t13-,14-,15-,16+,17-,18-,19-,20-,21-,22-/m1/s1 | 別名: | DECYLMALTOSIDE | 定義日: | 2003-12-02 | 最終更新日: | 2021-03-01 | 識別子(ID): | decyl 4-O-alpha-D-glucopyranosyl-beta-D-glucopyranoside |
|